Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides

Held, Stefanie Andrea Erika; Duchardt, Katharina Maria; Tenzer, Stefan; Rueckrich, Thomas; von Schwarzenberg, Karin; Bringmann, Anita; Kurts, Christian; Schild, Hansjoerg; Driessen, Christoph; Brossart, Peter; Heine, Annkristin

dc.contributor.author	Duchardt, Katharina Maria
dc.contributor.author	Rückrich, Thomas
dc.date.accessioned	2013-12-16T07:51:40Z
dc.date.available	2013-12-16T07:51:40Z
dc.date.issued	2013
dc.identifier.issn	0340-7004
dc.identifier.uri	http://hdl.handle.net/10900/39572
dc.language.iso	en	en
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00262-012-1373-7	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides	de_DE
dc.type	Article	de_DE
utue.quellen.id	20130911224530_01233	de_DE
utue.publikation.seiten	715-726	de_DE
utue.personen.roh	Held, Stefanie Andrea Erika
utue.personen.roh	Duchardt, Katharina Maria
utue.personen.roh	Tenzer, Stefan
utue.personen.roh	Rueckrich, Thomas
utue.personen.roh	von Schwarzenberg, Karin
utue.personen.roh	Bringmann, Anita
utue.personen.roh	Kurts, Christian
utue.personen.roh	Schild, Hansjoerg
utue.personen.roh	Driessen, Christoph
utue.personen.roh	Brossart, Peter
utue.personen.roh	Heine, Annkristin
dcterms.isPartOf.ZSTitelID	Cancer Immunology Immunotherapy	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	62	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE